Int. Journal of Drug cGMP
USA Edition : EU Edition : PR Edition

Locum International Press
Issues #1 - # 8

Eight issues /year.

The International Journal of Drug cGMP is available in three geographic zones (US ; EU and Pacific Rim).
The journal publishes articles, reviews and papers on all aspects on both Generic and Innovative Drug cGMP issues. Emphasis is places on current Good Clinical, Development, Validation, Manufacture, Laboratory, Analytical and Documentation Practices.

The US Journal highlights GMP exposure of the Drug Industry with special reference to the on-time development of NDA and ANDA submissions. Similar cGMP concepts are valid for the EU and Pacific Rim editions.

All aspects of pharmaceutical Good Practices covering practical hands-on nuts-and-bolts issues that vary across the full manufacturing spectrum, including drug excipients, formulations and processes, scale-up, analytical, cleaning and process validation necessary for the entire drug manufacture and control process to meet the agencies expectations.

The overall objective in cGMP is to maintain the current drug profile in the market place avoiding warning letters and negative PAI inspections.
The Journal attempts to clarify and simplify laboratory, manufacturing and control GMP, GLP GDP GVP and GRP issues to achieve this crucial objective.

80 - 95 pp illustrated b/w & color
Subscription Option Availability Print/CD/PDF via e-mail/Online

$1299.00 - Print Edition (single-user airmail print edition worldwide)
$1699.00 - Corporate single license single pharma campus - (Print / CD)
$1999.00 - Corporate multiple-user license - (print + CD edition maximizes distribution and readership for multiple pharma campus).

USA volume starts annually in March - Euro in June & Pacific Rim in September.

Online Members	DOWNLOAD from this JOURNAL	USA	Euro	Pacific
	The Journal Title and Cover Page >
Join IAGIM	The Journal's Annual Calendar >
	List of Worldwide Subscription Agents >